These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review. Nitsche KS; Müller I; Malcomber S; Carmichael PL; Bouwmeester H Arch Toxicol; 2022 Mar; 96(3):711-741. PubMed ID: 35103818 [TBL] [Abstract][Full Text] [Related]
6. Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms. Pridgeon CS; Schlott C; Wong MW; Heringa MB; Heckel T; Leedale J; Launay L; Gryshkova V; Przyborski S; Bearon RN; Wilkinson EL; Ansari T; Greenman J; Hendriks DFG; Gibbs S; Sidaway J; Sison-Young RL; Walker P; Cross MJ; Park BK; Goldring CEP Arch Toxicol; 2018 Feb; 92(2):557-569. PubMed ID: 29362863 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in microfluidic technologies for cell-to-cell interaction studies. Rothbauer M; Zirath H; Ertl P Lab Chip; 2018 Jan; 18(2):249-270. PubMed ID: 29143053 [TBL] [Abstract][Full Text] [Related]
8. 3D in vitro technology for drug discovery. Hosseinkhani H Curr Drug Saf; 2012 Feb; 7(1):37-43. PubMed ID: 22663957 [TBL] [Abstract][Full Text] [Related]
9. Special review series on 3D organotypic culture models: Introduction and historical perspective. Hayden PJ; Harbell JW In Vitro Cell Dev Biol Anim; 2021 Feb; 57(2):95-103. PubMed ID: 33237402 [TBL] [Abstract][Full Text] [Related]
10. 3D cell culture models and organ-on-a-chip: Meet separation science and mass spectrometry. Lin A; Sved Skottvoll F; Rayner S; Pedersen-Bjergaard S; Sullivan G; Krauss S; Ray Wilson S; Harrison S Electrophoresis; 2020 Jan; 41(1-2):56-64. PubMed ID: 31544246 [TBL] [Abstract][Full Text] [Related]
11. Developmentally inspired human 'organs on chips'. Ingber DE Development; 2018 May; 145(16):. PubMed ID: 29776965 [TBL] [Abstract][Full Text] [Related]
12. Microcavity array (MCA)-based biosensor chip for functional drug screening of 3D tissue models. Kloss D; Kurz R; Jahnke HG; Fischer M; Rothermel A; Anderegg U; Simon JC; Robitzki AA Biosens Bioelectron; 2008 May; 23(10):1473-80. PubMed ID: 18289841 [TBL] [Abstract][Full Text] [Related]
13. Accessing 3D microtissue metabolism: Lactate and oxygen monitoring in hepatocyte spheroids. Weltin A; Hammer S; Noor F; Kaminski Y; Kieninger J; Urban GA Biosens Bioelectron; 2017 Jan; 87():941-948. PubMed ID: 27665516 [TBL] [Abstract][Full Text] [Related]
14. Advances in reconstructing intestinal functionalities in vitro: From two/three dimensional-cell culture platforms to human intestine-on-a-chip. Wang L; Wu J; Chen J; Dou W; Zhao Q; Han J; Liu J; Su W; Li A; Liu P; An Z; Xu C; Sun Y Talanta; 2021 May; 226():122097. PubMed ID: 33676654 [TBL] [Abstract][Full Text] [Related]
15. Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates. Cavero I; Guillon JM; Holzgrefe HH Expert Opin Drug Saf; 2019 Aug; 18(8):651-677. PubMed ID: 31268355 [TBL] [Abstract][Full Text] [Related]
16. Cross-industrial applications of organotypic models. Kopanska KS; Rimann M ALTEX; 2022; 39(1):155-158. PubMed ID: 35034134 [TBL] [Abstract][Full Text] [Related]
17. Construction of 3D multicellular microfluidic chip for an in vitro skin model. Lee S; Jin SP; Kim YK; Sung GY; Chung JH; Sung JH Biomed Microdevices; 2017 Jun; 19(2):22. PubMed ID: 28374277 [TBL] [Abstract][Full Text] [Related]
18. Toxicological evaluation of airborne particulate matter. Are cell culture technologies ready to replace animal testing? Silvani S; Figliuzzi M; Remuzzi A J Appl Toxicol; 2019 Nov; 39(11):1484-1491. PubMed ID: 31025406 [TBL] [Abstract][Full Text] [Related]
19. Cultivating human tissues and organs over lab-on-a-chip models: Recent progress and applications. Bhagat S; Singh S Prog Mol Biol Transl Sci; 2022; 187(1):205-240. PubMed ID: 35094775 [TBL] [Abstract][Full Text] [Related]